Search Results Search Sort by RelevanceMost Recent Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708. Case and Commentary Aug 2017 How Should Physicians Help Gender-Transitioning Adolescents Consider Potential Iatrogenic Harms of Hormone Therapy? Thomas D. Steensma, PhD, S. Annelijn Wensing-Kruger, MSc, and Daniel T. Klink, MD, PhD Adolescents with gender dysphoria should be active participants in decisions about their gender-related health care. AMA J Ethics. 2017;19(8):762-770. doi: 10.1001/journalofethics.2017.19.8.ecas3-1708. Case and Commentary Nov 2016 How Should Physicians Refer When Referral Options Are Limited for Transgender Patients? Elizabeth Dietz and Jessica Halem, MBA In referring transgender patients for medical transition, clinicians should be guided by harm reduction, respect for autonomy, and continuity of care. AMA J Ethics. 2016;18(11):1070-1080. doi: 10.1001/journalofethics.2016.18.11.ecas1-1611. Case and Commentary Nov 2016 Should Mental Health Screening and Psychotherapy Be Required Prior to Body Modification for Gender Expression? Timothy F. Murphy, PhD Although patients’ medical gender transition can be facilitated by counseling, as a matter of medical ethics, informed consent must be obtained for treatment. AMA J Ethics. 2016;18(11):1079-1085. doi: 10.1001/journalofethics.2016.18.11.ecas2-1611. Case and Commentary Nov 2016 Should Psychiatrists Prescribe Gender-Affirming Hormone Therapy to Transgender Adolescents? Cary S. Crall, MD and Rachel K. Jackson In referring transgender patients for medical transition, clinicians should be guided by harm reduction, respect for autonomy, and continuity of care. AMA J Ethics. 2016;18(11):1086-1094. doi: 10.1001/journalofethics.2016.18.11.ecas3-1611. Case and Commentary Mar 2008 Duty to Warn and Dissociative Identity Disorder Michael A. Norko, MD How to treat a patient with a dissociative identity disorder and how to manage a threat made by one of the patient's personalities. Virtual Mentor. 2008;10(3):144-149. doi: 10.1001/virtualmentor.2008.10.3.ccas2-0803.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.
Case and Commentary Aug 2017 How Should Physicians Help Gender-Transitioning Adolescents Consider Potential Iatrogenic Harms of Hormone Therapy? Thomas D. Steensma, PhD, S. Annelijn Wensing-Kruger, MSc, and Daniel T. Klink, MD, PhD Adolescents with gender dysphoria should be active participants in decisions about their gender-related health care. AMA J Ethics. 2017;19(8):762-770. doi: 10.1001/journalofethics.2017.19.8.ecas3-1708.
Case and Commentary Nov 2016 How Should Physicians Refer When Referral Options Are Limited for Transgender Patients? Elizabeth Dietz and Jessica Halem, MBA In referring transgender patients for medical transition, clinicians should be guided by harm reduction, respect for autonomy, and continuity of care. AMA J Ethics. 2016;18(11):1070-1080. doi: 10.1001/journalofethics.2016.18.11.ecas1-1611.
Case and Commentary Nov 2016 Should Mental Health Screening and Psychotherapy Be Required Prior to Body Modification for Gender Expression? Timothy F. Murphy, PhD Although patients’ medical gender transition can be facilitated by counseling, as a matter of medical ethics, informed consent must be obtained for treatment. AMA J Ethics. 2016;18(11):1079-1085. doi: 10.1001/journalofethics.2016.18.11.ecas2-1611.
Case and Commentary Nov 2016 Should Psychiatrists Prescribe Gender-Affirming Hormone Therapy to Transgender Adolescents? Cary S. Crall, MD and Rachel K. Jackson In referring transgender patients for medical transition, clinicians should be guided by harm reduction, respect for autonomy, and continuity of care. AMA J Ethics. 2016;18(11):1086-1094. doi: 10.1001/journalofethics.2016.18.11.ecas3-1611.
Case and Commentary Mar 2008 Duty to Warn and Dissociative Identity Disorder Michael A. Norko, MD How to treat a patient with a dissociative identity disorder and how to manage a threat made by one of the patient's personalities. Virtual Mentor. 2008;10(3):144-149. doi: 10.1001/virtualmentor.2008.10.3.ccas2-0803.